Formulation and in vitro evaluation of inhalable dry powders containing solid lipid nanoparticlesJaspart, Séverine ; Delattre, Luc ; Evrard, Brigitte ![]() Poster (2007) Detailed reference viewed: 7 (1 ULg) Supercritical fluid technology to produce solid lipid microparticles; Jaspart, Séverine ; et alConference (2007) Detailed reference viewed: 16 (3 ULg) Contribution of cyclodextrins in the developement of different pharmaceutical formulations of a nex matrix metalloproteinase inhibitorEvrard, Brigitte ; ; Guéders, Maud et alin Journal of Inclusion Phenomena and Molecular Recognition in Chemistry (2007) Ro 28-2653 is a new synthetic inhibitor of matrix metalloproteinases. The ability of these enzymes to degrade various components of the extracellular matrix seems to play a major role in tumors ... [more ▼] Ro 28-2653 is a new synthetic inhibitor of matrix metalloproteinases. The ability of these enzymes to degrade various components of the extracellular matrix seems to play a major role in tumors progression and is potentially effective against bronchial remodeling in asthma and BPCO. Ro 28-2653 is very poorly soluble in water. This low solubility estimated at about 0.56 lg/ml in water at 25 C gives rise to difficulties in pharmaceutical formulation of oral, injectable or nebulizable solutions. The purpose of our study is to prepare and to characterize inclusion complexes between Ro 28-2653 and cyclodextrins and to investigate the biopharmaceutical repercussion of the inclusion of the active substance.The complex formation was investigated by phase solubility studies. 1H-NMR spectroscopy and molecular modeling studies were carried out to elucidate the structure of the inclusion complex between Ro 28-2653 and cyclodextrin. Oral, intravenous and nebulizable solutions of Ro 28-2653 were developed with cyclodextrin. The in vivo studies were performed on healthy sheep for the pharmacokinetic evaluation of the oral and intravenous formulations while the nebulization of the complex solution was studied by using an asthma model in mouse. [less ▲] Detailed reference viewed: 21 (12 ULg) Effect of cyclodextrins on the viability of endothelial cellsCastagne, Delphine ; ; Delattre, Luc et alin Journal of Inclusion Phenomena and Macrocyclic Chemistry (2007), 57(1-4), 105-107 Detailed reference viewed: 15 (2 ULg) Encapsulation of betamethasone-HP-gCD complex in deformable liposomesPiel, Géraldine ; Ducat, Emilie ; Grammenos, Angeliki et alPoster (2007) Detailed reference viewed: 3 (1 ULg) DEVELOPMENT OF AN INTRAPERITONEAL IMPLANT FOR THE ENDOMETRIOSIS TREATMENTKrier, Fabrice ; ; Riva, Raphaël et alConference (2007) Detailed reference viewed: 17 (3 ULg) Controlled release of drugs from an original multi-component device; ; Collard, Laurence et alPoster (2007) Detailed reference viewed: 17 (9 ULg) Optimization of drug-cyclodextrin complexation reaction by a static supercritical carbon dioxide method; ; Piel, Géraldine et alConference (2007) Detailed reference viewed: 6 (0 ULg) Optimisation de la réaction de complexation entre une cyclodextrine et un composé pharmaceutique par utilisation du CO2 supercritque; ; Piel, Géraldine et alConference (2007) Detailed reference viewed: 16 (0 ULg) Studies on the structure of cationic liposomes/siRNA complexes by zeta potential and size measurementDehousse, Vincent ; Piel, Géraldine ; Delattre, Luc et alConference (2007) Detailed reference viewed: 19 (3 ULg) Theoretical and experimental investigations on miconazole/cyclodextrin/acid complexes: Molecular modeling studies; Dive, Georges ; et alin International Journal of Pharmaceutics (2007), 342(1-2), 152-160 The inclusion of miconazole into cyclodextrin cavity has been demonstrated by different authors. Preliminary studies have shown which fragment of the molecule is involved in the inclusion. In the present ... [more ▼] The inclusion of miconazole into cyclodextrin cavity has been demonstrated by different authors. Preliminary studies have shown which fragment of the molecule is involved in the inclusion. In the present study, AM1 approximate molecular orbital calculations have been performed on several cyclodextrins complexes ( CD, HP CD and HP CD) with miconazole and acidic compounds (maleic, fumaric and L-tartaric acids) as partners. For all the binary complexes, the inclusion of the dichlorobenzene–CH2–O-group leads to the most stable complex. For the ternary complexes, depending on their conformation and/or their structures, the acids can either stabilize or destabilize the complex. All the theoretical results were in good agreement with experimental data of miconazole inclusion yields into cyclodextrins. This work clearly demonstrates that the structure of both cyclodextrin and acid plays a key-role in the formation of inclusion complexes. [less ▲] Detailed reference viewed: 53 (21 ULg) Effect of cyclodextrin derivatives on bronchial epithelial cell layer permeability; ; Delattre, Luc et alPoster (2007) Detailed reference viewed: 23 (1 ULg) Controlled release of drugs from an original multi-component device; ; Collard, Laurence et alPoster (2007) Detailed reference viewed: 6 (0 ULg) Controlled release of drug from multicomponent device; ; Jérôme, Christine et alPoster (2007) Detailed reference viewed: 4 (1 ULg) Development of an original intra-uterine implant allowed specific release kinetics of several drugs; ; Collard, Laurence et alPoster (2007) Detailed reference viewed: 20 (1 ULg) Kleptose Crysmeb is a biocompatiblecyclodextrin solubiliser for pulmonary delivery of Ro 28-2653, a new synthetix matrix metalloproteinase inhibitor; ; Delattre, Luc et alPoster (2007) Detailed reference viewed: 37 (0 ULg) Mucoadhesive composition comprising polyacrylate and chemoattractantHubert, Pascale ; Evrard, Brigitte ; Delattre, Luc et alPatent (2006) Detailed reference viewed: 23 (1 ULg) Assessment of betamethasone-in-cyclodextrin-in-liposome induced skin blanching responsePiel, Géraldine ; Coia, Isabelle ; Uhoda, Emmanuelle et alPoster (2006, October) Detailed reference viewed: 19 (9 ULg) Linking compaction dynamics to the flow properties of powdersLumay, Geoffroy ; Vandewalle, Nicolas ; Delattre, Luc et alin Applied Physics Letters (2006), 89(9), The authors have investigated the flow properties of powders by using two classical techniques based on the shear stress measurements and the count of intermittent avalanches, respectively. Results are ... [more ▼] The authors have investigated the flow properties of powders by using two classical techniques based on the shear stress measurements and the count of intermittent avalanches, respectively. Results are compared with measurements of the compaction dynamics. Strong correlations are evidenced between compaction relaxation parameters and free flow characteristics. Those correlations are given by semiempirical laws based on physical arguments. This work opens perspectives in powder technology and the knowledge on granular matter. (c) 2006 American Institute of Physics. [less ▲] Detailed reference viewed: 20 (5 ULg) MUCOADHESIVE PHARMACEUTICAL COMPOSITIONS COMPRISING CHEMOATTRACTANTS.Herman, Ludivine ; Hubert, Pascale ; Delvenne, Philippe et alPatent (2006) Detailed reference viewed: 25 (8 ULg) |
||